These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31798777)

  • 1. Non-coding RNA in drug resistance of gastric cancer.
    Luo YJ; Huang QM; Ren Y; Liu ZL; Xu CF; Wang H; Xiao JW
    World J Gastrointest Oncol; 2019 Nov; 11(11):957-970. PubMed ID: 31798777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.
    Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC
    Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs underlying chemoresistance in gastric cancer.
    Poursheikhani A; Bahmanpour Z; Razmara E; Mashouri L; Taheri M; Morshedi Rad D; Yousefi H; Bitaraf A; Babashah S
    Cell Oncol (Dordr); 2020 Dec; 43(6):961-988. PubMed ID: 32495294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNAs Roles in Chemoresistance of Cancer Cells.
    Taghvimi S; Abbaszadeh S; Banan FB; Fard ES; Jamali Z; Najafabadi MA; Savardashtaki A; Movahedpour A
    Curr Mol Med; 2022; 22(8):691-702. PubMed ID: 34711162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications.
    Chen D; Ping S; Xu Y; Wang M; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
    Front Cell Dev Biol; 2021; 9():732036. PubMed ID: 34805143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
    Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
    Front Genet; 2021; 12():693259. PubMed ID: 34512721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of autophagy by non-coding RNAs in gastric cancer.
    Wang Z; Liu J; Xie J; Yuan X; Wang B; Shen W; Zhang Y
    Front Oncol; 2022; 12():947332. PubMed ID: 36353541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Exosomal Non-coding RNAs in Gastric Cancer: Biological Functions and Potential Clinical Applications.
    Hu F; Liu J; Liu H; Li F; Wan M; Zhang M; Jiang Y; Rao M
    Front Oncol; 2021; 11():700168. PubMed ID: 34195097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs in Lung Cancer Chemoresistance.
    Mondal P; Natesh J; Kamal MA; Meeran SM
    Curr Drug Metab; 2019; 20(13):1023-1032. PubMed ID: 31906835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer.
    Liu Y; Ao X; Ji G; Zhang Y; Yu W; Wang J
    Front Oncol; 2021; 11():768918. PubMed ID: 34912714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Network of Non-coding RNAs in Cancer Drug Resistance.
    Corrà F; Agnoletto C; Minotti L; Baldassari F; Volinia S
    Front Oncol; 2018; 8():327. PubMed ID: 30211115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.
    Liu Y; Ao X; Wang Y; Li X; Wang J
    Front Oncol; 2022; 12():841411. PubMed ID: 35155266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review.
    Li Z; Lü M; Zhou Y; Xu L; Jiang Y; Liu Y; Li X; Song M
    Onco Targets Ther; 2021; 14():503-518. PubMed ID: 33500626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in gastric cancer.
    Wang J; Song YX; Wang ZN
    Gene; 2015 Apr; 560(1):1-8. PubMed ID: 25659765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
    Chen M; Lei N; Tian W; Li Y; Chang L
    Ther Adv Med Oncol; 2022; 14():17588359221118010. PubMed ID: 35983027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrevealing the vital role of ncRNAs in Gastric Cancer chemoresistance.
    Kazemi A; Goodarzi M; Daneshipour K; Sarabadani H; Shahpar Z; Hajiagha BS; Kheradjoo H; Mohammadzadehsaliani S
    Pathol Res Pract; 2023 Oct; 250():154761. PubMed ID: 37689003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.